AGC Equity Partners
AGC Equity Partners is a global alternative asset investment firm based in London, with additional offices in the Middle East. Founded in 2009, the firm manages over $6 billion in equity capital and specializes in private equity, secondaries, and real estate investments. AGC focuses on identifying and capitalizing on opportunities created by market dislocations, particularly in Europe and North America, aiming to deliver above-market returns across various asset classes. The firm employs a hands-on approach to value creation, leveraging the expertise of its investment team to source superior investment opportunities and structure innovative transaction solutions. AGC has cultivated strong relationships with prominent sovereign, institutional, and ultra-high-net-worth investors, who collaborate with the firm in pursuit of optimal investment strategies.
ConforMIS
Series E in 2013
ConforMIS is a medical technology company based in the United States that specializes in joint replacement implants and instruments. Utilizing its proprietary iFit® Image-to-Implant® technology platform, ConforMIS develops and manufactures personalized implants that are uniquely sized and shaped to match each patient's anatomy. The company's offerings include a wide range of sterile knee and hip implants, such as partial and total knee replacements, along with single-use surgical instruments. ConforMIS's iFit technology encompasses design, printing, and just-in-time delivery, allowing for customized solutions that enhance patient outcomes. The company primarily generates revenue through sales to hospitals and ambulatory surgical centers, positioning itself within the knee replacement market.
Evernote
Secondary Market in 2012
Evernote Corporation is a software company that develops and markets applications designed for mobile phones, tablets, and computers, catering to both individuals and businesses globally. Founded in 2004 and headquartered in Redwood City, California, Evernote provides a suite of tools that facilitate note-taking, organization, and information management. Its flagship application allows users to write, collect, and present ideas seamlessly across devices. Additional offerings include Skitch, which enables visual communication through annotations and sketches; Scannable, which transforms paper documents into digital scans; Evernote Web Clipper, for saving web content; and Penultimate, a handwriting app for iPad. With a user base exceeding 100 million, Evernote's innovative solutions aim to enhance productivity and streamline workflows for its customers. The company operates independently and continues to expand its offerings and team.
ConforMIS
Series E in 2012
ConforMIS is a medical technology company based in the United States that specializes in joint replacement implants and instruments. Utilizing its proprietary iFit® Image-to-Implant® technology platform, ConforMIS develops and manufactures personalized implants that are uniquely sized and shaped to match each patient's anatomy. The company's offerings include a wide range of sterile knee and hip implants, such as partial and total knee replacements, along with single-use surgical instruments. ConforMIS's iFit technology encompasses design, printing, and just-in-time delivery, allowing for customized solutions that enhance patient outcomes. The company primarily generates revenue through sales to hospitals and ambulatory surgical centers, positioning itself within the knee replacement market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.